Financial Performance - Q3 2025 revenue was CNY 265,258,563.69, a decrease of 4.00% year-over-year[6] - Net profit attributable to shareholders was CNY 21,547,375.35, down 1.44% compared to the same period last year[6] - Net profit excluding non-recurring items dropped by 65.43% to CNY 6,634,407.68[6] - Total profit decreased to ¥62,511,546.76, down 38.75% year-over-year, attributed to increased depreciation from fixed asset transfers and higher R&D expenses[10] - Net profit for the period was ¥54,416,274.80, representing a decline of 35.99% compared to the previous year[10] - Total operating revenue for the current period is ¥823,004,651.62, a decrease of 0.5% from ¥826,447,909.29 in the previous period[19] - Total operating costs increased to ¥815,792,926.85, up 10% from ¥741,453,727.58 in the previous period[19] - Net profit for the current period is ¥54,416,274.80, down 36% from ¥85,016,205.39 in the previous period[20] - Basic and diluted earnings per share decreased to ¥0.26 from ¥0.42 in the previous period[21] Cash Flow - Cash flow from operating activities decreased significantly by 86.53% to CNY 17,717,038.09[6] - Cash flow from operating activities saw a significant drop to ¥17,717,038.09, down 86.53% year-over-year, due to reduced cash receipts from sales[11] - Cash inflow from investment activities surged to ¥867,618,898.51, an increase of 199.48%, driven by stock disposals and dividends from joint ventures[11] - Cash outflow for investment activities rose to ¥904,053,524.66, up 70.84%, primarily due to increased purchases of stocks and financial products[11] - Cash flow from investing activities resulted in a net outflow of ¥36,434,626.15, compared to a net outflow of ¥239,482,060.20 in the previous period[22] - Cash flow from financing activities showed a net outflow of ¥12,230,658.73, improving from a net outflow of ¥224,669,581.83 in the previous period[22] - The ending balance of cash and cash equivalents is ¥294,168,413.55, down from ¥370,076,129.53 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,867,316,553.71, a decrease of 0.64% from the previous year[6] - The company's total assets decreased from CNY 2,885,699,417.44 to CNY 2,867,316,553.71, a decline of approximately 0.63%[16] - Current assets increased slightly from CNY 1,118,881,798.69 to CNY 1,133,089,243.45, an increase of about 1.3%[16] - The company's cash and cash equivalents decreased from CNY 327,731,235.40 to CNY 297,000,055.31, a decrease of approximately 9.4%[16] - Short-term borrowings increased significantly from CNY 137,810,018.05 to CNY 194,034,555.56, an increase of about 40.6%[17] - Total liabilities increased from CNY 1,057,771,514.20 to CNY 1,105,736,886.46, an increase of approximately 4.5%[18] - The company's equity attributable to shareholders decreased from CNY 1,740,925,704.26 to CNY 1,668,520,755.19, a decline of about 4.1%[18] Receivables and Investments - The company reported a 40.84% increase in receivables financing, totaling CNY 111,090,221.30[9] - Other receivables surged by 407.58% to CNY 21,593,947.31, primarily due to acquisition-related payments[9] - Investment income increased significantly to ¥40,582,174.30, up 444.35% compared to the previous period, primarily due to stock trading gains and equity transfer from subsidiaries[10] - Profit from joint ventures rose to ¥15,566,287.80, reflecting a 117.91% increase, mainly from equity transfer gains from Shanghai Jiucheng Packaging Co., Ltd.[10] - The company's long-term investments decreased from CNY 201,845,848.77 to CNY 187,301,636.57, a decline of approximately 7.2%[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,499, with the largest shareholder holding 29.98% of the shares[13] - The company reported a total of 10,088,375 shares held in the repurchase account, accounting for 5.21% of the total share capital[16] Other Information - The company's basic earnings per share remained stable at CNY 0.12, but diluted earnings per share also stayed at CNY 0.12[6] - The third quarter financial report of Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd. has not been audited[23] - The new accounting standards will be implemented starting from 2025[23] - The financial statement items related to the first year of the new accounting standards will be adjusted at the beginning of the year[23]
海顺新材(300501) - 2025 Q3 - 季度财报